**
On 27 April 2026, the United States Supreme Court convened to deliberate a pivotal case regarding the liability of pesticide manufacturers, particularly concerning glyphosate, a herbicide linked to cancer. The case, Monsanto v. Durnell, challenges whether federal regulations inhibit state-level lawsuits against companies for failing to adequately warn consumers about the potential health risks of their products. As the court heard arguments, demonstrators rallied outside, voicing their concerns about corporate accountability and public health.
The Legal Battle over Glyphosate
The core of the Supreme Court’s review revolves around glyphosate, a key ingredient found in the popular Roundup herbicide, produced by Monsanto, now a subsidiary of Bayer AG. This chemical has been classified as a “probable human carcinogen” by the World Health Organization since 2015, and numerous studies have pointed to its potential link to non-Hodgkin lymphoma. Bayer has faced a monumental wave of over 100,000 lawsuits from individuals alleging that their health deteriorated due to exposure to glyphosate-based products, resulting in payouts totaling billions of dollars in settlements and jury awards.
During the recent oral arguments, justices probed the legal implications of federal pesticide regulations under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Bayer’s legal team contended that the EPA’s assessment deeming glyphosate “unlikely” to be carcinogenic absolves them of certain liabilities. They argued that since the EPA has not mandated warning labels regarding cancer risks, Monsanto should not be held accountable for failing to provide such disclosures.
Paul Clement, attorney for Monsanto, emphasised that FIFRA’s provisions aim to maintain consistent safety standards across the nation, implying that allowing states to impose additional requirements could disrupt agricultural practices. “Congress plainly wanted uniformity when it came to the safety warnings on a pesticide’s label,” he stated, cautioning against the potential chaos that could ensue from divergent state regulations.
Divergent Views on Pesticide Safety
Countering Monsanto’s arguments, attorney Ashley Keller highlighted significant flaws in the EPA’s registration processes, asserting that FIFRA does not grant the sweeping immunity claimed by the pesticide giant. Keller pointed to a 2022 ruling by the Ninth Circuit Court of Appeals, which vacated the EPA’s findings on glyphosate due to failures in adhering to established cancer risk assessment protocols.
The justices displayed a range of reactions during the hearing. Many appeared sceptical of Monsanto’s stance, particularly regarding how new scientific data might influence labeling requirements amidst ongoing reviews by the EPA. The court’s three liberal justices seemed particularly doubtful, while the positions of the remaining justices remained less clear.
Public Outcry and Legislative Implications
Outside the Supreme Court, a passionate crowd gathered to protest against the perceived lack of accountability from corporations like Monsanto. Organised by the Maha movement, demonstrators carried placards with messages such as “Roundup the guilty” and “Make Monsanto pay”. Zen Honeycutt, a prominent activist and founder of Moms Across America, articulated the urgency of their cause, stating, “We will not stand for being poisoned any more. These companies must have accountability, and it starts today.”
Among the protesters was Chellie Pingree, a Democratic representative from Maine, who has long advocated for stricter regulations on harmful chemicals in agriculture. “To have so many people show up from all over the country, united in keeping poisons out of our food and environment, is a big day,” she remarked, highlighting the bipartisan nature of the movement against glyphosate.
As the Supreme Court deliberates, the House of Representatives is also considering the new Farm Bill, which includes provisions that could reshape the legal landscape for pesticide manufacturers. Bipartisan amendments proposed by Pingree and Republican representative Thomas Massie aim to strip protections that shield chemical companies from lawsuits and preempt state regulations on warning labels.
Why it Matters
The outcome of this Supreme Court case carries significant implications not only for the future of glyphosate and its manufacturers but also for consumer rights and public health advocacy. A ruling in favour of Monsanto could severely limit the ability of individuals to seek justice in cases involving hazardous chemicals, potentially emboldening other pesticide manufacturers to evade accountability. Conversely, a decision that favours the plaintiffs could pave the way for heightened scrutiny of pesticide safety standards, reinforcing the necessity for transparent consumer warnings and the prioritisation of public health over corporate interests. As the court prepares to issue its ruling this summer, the stakes could not be higher for consumers, farmers, and the environment alike.
